Welcome to the information site on computational systems biology services and solutions by Bayer provided to the healthcare industry.
To gain comprehensive understanding about biological systems, their interaction with pharmaceuticals and the complex dynamical processes involved, Bayer relies on mechanistic modeling.
With the aim of supporting decision making along the pharma research and development process, we offer software products for predictive simulation of drug behavior and modeling of cellular pathways, integrating many years of in-house and external market experience.
To access a selection of our publications and conference posters offering more detailed information on our work, please follow the link to our Literature pages. If you would like to know more about how we pursue our research mission statement - to perform frontier research and transform results into cutting edge products to support drug development - please check our Research section.
December 19, 2016
New publications regarding PBPK modeling: Elderly, Isoniazid, DDI and Diabetes. In addition: A white paper regarding good practices in drug discovery and development
October 18, 2016
Published in CPT Pharmacometrics & Systems Pharmacology: Applied Concepts in PBPK modeling: How to build a PBPK/PD model
September 15, 2016
New Version Release: Computational Systems Biology Software Suite Version 6.3